Hydrocortisone valerate and Ketoconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydrocortisone valerate (hydrocortisone valerate) and Ketoconazole (ketoconazole). Common drug interactions include arthralgia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Hydrocortisone valerate and Ketoconazole. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Hydrocortisone valerate?

Hydrocortisone valerate has active ingredients of hydrocortisone valerate. eHealthMe is studying from 609 Hydrocortisone valerate users. Check the latest studies of Hydrocortisone valerate.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.

On Jul, 13, 2026

45 people who take Hydrocortisone valerate and Ketoconazole together, and have interactions are studied.

Hydrocortisone valerate and Ketoconazole drug interactions.

What are the common drug interactions of Hydrocortisone Valerate and Ketoconazole, by gender? *:

female:

Arthralgia (joint pain)
Bone pain
Chest pain
Cough
Drug administration error
Drug ineffective
Drug intolerance (drug sensitivity)
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Dry mouth
Dysstasia (difficulty in standing)

male:

Anxiety
Chronic kidney disease
Pain
Rhinitis allergic (inflammation of the nasal airways due to allergy)
B-cell lymphoma (blood cancer affecting b cells)
Conjunctivitis (pink eye)
Cough
Depression
Ear infection
Pyrexia (fever)

What are the common drug interactions of Hydrocortisone Valerate and Ketoconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

B-cell lymphoma (blood cancer affecting b cells)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Conjunctivitis (pink eye)
Cough
Ear infection
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Eczema eyelids (patches of skin become rough and inflamed, with itching and bleeding blisters on eyelid)
Pyrexia (fever)
Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)
Rhinitis allergic (inflammation of the nasal airways due to allergy)

10-19:

n/a

20-29:

n/a

30-39:

Injection site erythema (redness at injection site)
Injection site pain
Injection site pruritus (severe itching at injection site)
Injection site swelling
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Headache (pain in head)
Hepatocellular damage (liver damage)
Nasopharyngitis (inflammation of the nasopharynx)
Nephropathy (damage to or disease of a kidney)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

40-49:

n/a

50-59:

Poor quality sleep
Post thrombotic syndrome (long-term effects that can occur after venous thrombosis)
Radius fracture
Renal tubular necrosis (death of kidney tubules)
Respiratory failure (inadequate gas exchange by the respiratory system)
Rib fracture
Septic shock (shock due to blood infection)
Stomatitis (inflammation of mucous membrane of mouth)
Streptococcal infection
Swelling face

60+:

Blood pressure fluctuation
Confusional state
Lymphocyte count decreased
Upper respiratory tract infection
Alopecia (absence of hair from areas of the body)
Anxiety
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Chest pain
Chronic kidney disease
Drug administration error

What are the existing conditions these people have? *

Hiv Infection: 12 people, 26.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 7 people, 15.56%
Psoriasis (immune-mediated disease that affects the skin): 6 people, 13.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 13.33%
Pain: 4 people, 8.89%
Rashes (redness): 3 people, 6.67%
High Blood Pressure: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocortisone valerate and Ketoconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously